Now published: CTRad: identifying opportunities to promote progress in molecular radiotherapy research in the UK
NCRI’s Clinical and Translational Radiotherapy Research Working Group (CTRad) has published its review of molecular radiotherapy (MRT) research in the UK.MRT has considerable potential to benefit patients, and could provide further scope for improved patient outcomes, however research in MRT has lagged behind that of other cancer therapies. To help assess the needs and opportunities in UK MRT research, CTRad consulted with the UK MRT community to ascertain the range of research activity and the barriers preventing progress. The feedback identified opportunities for improvement as well as a number of barriers and challenges. This report identifies three strategic priorities and provides a number of recommendations for each that will promote progress in MRT research.